Pediatric Leukemia and Lymphoma Steering Committee
The Pediatric Leukemia and Lymphoma Steering Committee (PLLSC) was established in 2011. PLLSC members include representatives from the Children's Oncology Group, pediatric and medical oncologists and other specialists, translational scientists, biostatisticians, patient advocates, and NCI staff.
The PLLSC follows a data-driven, transparent process to identify and promote the best science in clinical research for pediatric and adolescent patients with leukemia, lymphoma, and other hematologic malignancies by evaluating and prioritizing phase II and phase III clinical trial concepts.
Roster of Pediatric Leukemia and Lymphoma Steering Committee (PLLSC) members
David Poplack, M.D. - Chair; Robert Arceci, M.D., Ph.D. - Vice Chair
Clinical Trial Planning Meetings (CTPMs): Goal of Clinical Trial Planning Meetings, and List of CTPM Executive Summaries and Publications
CCCT Contact: Wolf Lindwasser, Ph.D.